Tumilty et al.
The recent publication of the interim report of the PHARMAC Review Panel raises important questions of the role and processes of PHARMAC in securing equitable access to pharmaceuticals for all New Zealanders.
The recent publication of the interim report of the PHARMAC Review Panel raises important questions of the role and processes of PHARMAC in securing equitable access to pharmaceuticals for all New Zealanders.
New Zealand’s pharmaceutical sector is cautiously optimistic over the industry being granted an exemption from US President Donald Trump’s tariffs.
The legislation will give the health minister the power to approve, reject or transfer medication applications
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its producer hoping to make it accessible “as soon as possible”.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI